Cardiovascular diseases account for approximately 35% of all deaths in women globally, with a 2019 age-standardized prevalence of 6,403 per 100,000 and mortality of 204 per 100,000.
This review highlights the global burden of CVD in women, emphasizing the need to address socioeconomic determinants, delayed diagnoses, and knowledge gaps to improve outcomes.
Cardiovascular diseases (CVDs) are responsible for approximately 35% of all deaths in women. In 2019, the global age-standardized CVD prevalence and mortality of women were 6,403 per 100,000 and 204 per 100,000, respectively. Although the age- and population-adjusted prevalence has decreased globally, opposite trends are evident in regions of socioeconomic deprivation. Cardiovascular health and outcomes are influenced by regional socioeconomic, environmental, and community factors, in addition to health care system and individual factors. Cardiovascular care in women is commonly plagued by delayed diagnoses, undertreatment, and knowledge gaps, particularly in women-specific or women-predominant conditions. In this paper, we describe the global epidemiology of CVD and highlight multilevel determinants of cardiometabolic health. We review knowledge and health care gaps that serve as barriers to improving CVD outcomes in women. Finally, we present national, community, health care system, and research strategies to comprehensively address cardiometabolic risk and improve outcomes in women.
Vervoort et al. (Sat,) conducted a review in Cardiovascular disease. Cardiovascular diseases account for approximately 35% of all deaths in women globally, with a 2019 age-standardized prevalence of 6,403 per 100,000 and mortality of 204 per 100,000.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: